{"id":"W2020428172","doi":"10.1111/bjh.13100","title":"Phase I‐<scp>II</scp> trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Southlake Regional Health Center; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene","keywords":"Medicine; Lenalidomide; Prednisone; Refractory (planetary science); Cyclophosphamide; Internal medicine; Regimen; Multiple myeloma; Surgery; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001896989,0.001765122,0.002016346,0.0005116216,0.000400454,0.0009814211,0.001085513,0.001280037,0.002724528],"category_scores_gemma":[0.0008699441,0.0004898835,0.001298362,0.0004802862,0.0008070478,0.0005772414,0.0005170464,0.004064019,0.0007211263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00120293,"about_ca_system_score_gemma":0.001876112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001015666,"about_ca_topic_score_gemma":0.003098079,"domain_scores_codex":[0.9993752,0.0003721672,0.00002605621,0.00008442768,0.0000643426,0.00007789422],"domain_scores_gemma":[0.9992478,0.0001182447,0.0001995788,0.00004754873,0.00004272089,0.0003441132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7502645,0.04727594,0.005678508,0.0009520891,0.001944189,0.000284032,0.0002390537,0.003425645,0.03409509,0.000389993,0.008626387,0.1468246],"study_design_scores_gemma":[0.7761635,0.2090954,0.006783472,0.00005358355,0.0003853239,0.000296505,0.00002616424,0.001436895,0.002550588,0.0001846137,0.002996444,0.00002764641],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819691,0.004135937,0.0008640242,0.001193259,0.0002388189,0.006091529,0.00148975,0.0002243973,0.00379327],"genre_scores_gemma":[0.9746178,0.002907841,0.004471488,0.002236559,0.0004117403,0.005939925,0.004856095,0.00006063566,0.004497896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002724528,"threshold_uncertainty_score":0.01003236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01816170345792047,"score_gpt":0.2891611842760655,"score_spread":0.270999480818145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}